Companies: 10,795·Total market cap: $144.5T
Invion Limited

Invion Limited

IVIXFOTCHealthcare● Active
$0.00
$-0.04(-95.12%)
Market Cap$174538
P/E Ratio
52W High$0.0369
52W Low$0.0018

Invion Limited (IVIXF) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

IVIXF · cash on hand · updated Jun 30, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$559,676 -28.6% vs prior year
FY · as of Jun 30, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$559,676
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-28.6%
vs prior fiscal year
Latest Quarter
$91,775
Q4 2025
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: June 30, 2025

Net cash vs debt

Cash & ST Investments$559,676Cash on Hand
Total Debt$0Total Debt
Net Cash / Net Debt+$559,676Net Cash Position
Cash vs Debt Ratio
Cash 100%Debt 0%

Invion Limited has a net cash position of $559,676, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$559,676$0 = +$559,676

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
IVIXF annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Jun 30, 2025Latest$0.6M-28.6%
Jun 30, 2024$0.8M-71.2%
Jun 30, 2023$2.7M-53.5%
Jun 30, 2022$5.8M+651.1%
Jun 30, 2021$0.8M+82.7%
IVIXF cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Invion Limited
Invion LimitedYOU
IVIXF
$0.6M320.7%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Invion Limited (IVIXF) cash on hand as of June 30, 2025 is $559,676, comprising $559,676 in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Invion Limited cash and short-term investments on the balance sheet (10-K filing). Also referred to as Invion Limited cash reserves or cash position.

Invion Limited annual cash on hand history shows decreased -28.6% in 2025: decreased -28.6% in 2025. Invion Limited cash reserves in 2025 reflect the company's capital allocation strategy.

Invion Limited carries total debt of $0 against cash of $559,676, resulting in a net cash position of +$559,676. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

IVIXF cash on hand · 5 questions

As of June 30, 2025, Invion Limited (IVIXF) has $559,676 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $559,676 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (December 31, 2025): $91,775. Data sourced from the annual 10-K filing via FMP.

IVIXF cash on handIVIXF cash reservesIVIXF cash 2025how much cash does IVIXF have

Source: FMP /balance-sheet-statement · US GAAP · Invion Limited · Invion Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: June 30, 2025